As of 17 Sept 2026, Indraprastha Medical Corporation Ltd share price is ₹356.85. The stock opened at ₹356.85 and had closed at ₹354.90 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹342.35 and a high of ₹640.05. In terms of performance, Indraprastha Medical Corporation Ltd share price has decreased by 8.73% over the past six months and has decreased by 25.35% over the last year.
INDRAMEDCO Stock Price Chart
Indraprastha Medical Corporation Ltd Overview
About INDRAMEDCO
Indraprastha Medical Corporation operates the flagship Indraprastha Apollo Hospitals and is a prominent public-private partnership healthcare provider in India.
Indraprastha Medical Corporation Ltd Historical Performance
Indraprastha Medical Corporation Ltd Fundamentals
Indraprastha Medical Corporation Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,511.26 | 1,379.01 | 1,261.59 | 1,108.70 | 891.28 |
| EBITDA | 295.67 | 266.92 | 210.25 | 160.73 | 117.42 |
| Net Profit | 183.62 | 160.99 | 123.96 | 86.15 | 58.62 |
| EPS | 20.03 | 17.56 | 13.52 | 9.40 | 6.39 |
Indraprastha Medical Corporation Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 350.87 |
| Resistance 1 (R1) | 359.42 |
| Pivot Point | 355.38 |
Indraprastha Medical Corporation Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 18-Sep-2025 | 15-May-2025 | 18-Sep-2025 | Final | ₹4.50 |
| 13-Sep-2024 | 17-May-2024 | 14-Sep-2024 | Final | ₹4.50 |
| 15-Sep-2023 | 23-May-2023 | 16-Sep-2023 | Final | ₹3.00 |
| 15-Sep-2022 | 20-May-2022 | 17-Sep-2022 | Final | ₹2.50 |
INDRAMEDCO Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Prathap C Reddy | Vice Chairman |
| Suneeta Reddy | Non Executive Independent Director |
| Sangita Reddy | Non Executive Independent Director |
Indraprastha Medical Corporation Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,696.50-0.20% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,025.00-0.49% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹870.30-1.11% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Indraprastha Medical Corporation Ltd today is ₹356.85 on NSE and ₹356.85 on BSE.
- The 52-week high of Indraprastha Medical Corporation Ltd is ₹640.05, while the 52-week low is ₹342.35.
- The current market capitalisation of Indraprastha Medical Corporation Ltd is approximately ₹3,271 crore.
- The P/E (Price-to-Earnings) ratio of Indraprastha Medical Corporation Ltd is 17.40. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Indraprastha Medical Corporation Ltd is 4.42. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Indraprastha Medical Corporation Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for INDRAMEDCO on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Indraprastha Medical Corporation Ltd has delivered a return of approximately 120.43%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Indraprastha Medical Corporation Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 51.00% promoters, 2.75% FIIs, 0.59% DIIs, and 32.61% public shareholders.

